CTT PHARMACEUTICAL HOLDINGS, INC.
CIK:
0001035422
Company Information
Industry
Gold and Silver Ores
SIC Code
1040
Entity Type
operating
SEC Category
Smaller reporting company
State of Incorporation
DE
Business Address
3853 NORTHDALE BLVD #268, TAMPA, FL, 33624
Mailing Address
3853 NORTHDALE BLVD #268, TAMPA, FL, 33624
Phone
813-606-0060
Fiscal Year End
1231
EIN
113763974
Financial Overview
FY2014
$228K
Net Income
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 17, 2025 | View on SEC |
| 4 Insider stock transaction report | November 24, 2025 | View on SEC |
| 4 Insider stock transaction report | November 21, 2025 | View on SEC |
| 4 Insider stock transaction report | October 31, 2025 | View on SEC |
| 4 Insider stock transaction report | October 7, 2025 | View on SEC |
| 4 Insider stock transaction report | September 23, 2025 | View on SEC |
| 4 Insider stock transaction report | August 1, 2025 | View on SEC |
| 4 Insider stock transaction report | July 8, 2025 | View on SEC |
| 4 Insider stock transaction report | June 30, 2025 | View on SEC |
IPO Filings
S-1
December 30, 2025
- Developing innovative treatments for chronic inflammatory diseases, focusing on a promising drug candidate for autoimmune diseases.
- IPO proceeds are primarily allocated to funding crucial clinical trials, expanding R&D, and preparing for manufacturing.
Insider Trading
BUY
1 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 1040)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.